about
Apolipoprotein A1LPLLipoprotein lipaseLCATLecithin cholesterol acyltransferaseApolipoprotein A-ILipase, hepaticAPOC2Apolipoprotein A5Apolipoprotein A-IVApolipoprotein EApolipoprotein A-IVApolipoprotein A-VLipase, endothelialLipase G, endothelial typeApolipoprotein A4Apolipoprotein A5Apolipoprotein A1Lipase G, endothelial typeApolipoprotein ELipoprotein lipaseLecithin cholesterol acyltransferaseLipase, endothelialApolipoprotein A-IV aCholesteryl ester transfer protein, plasmaApolipoprotein A-IbApolipoprotein A-IV b, tandem duplicate 3Apolipoprotein A-IV b, tandem duplicate 1Si:dkey-7f3.14Apolipoprotein EbLipoprotein lipase-likeApolipoprotein C2Lipoprotein lipaseCholesteryl ester transfer proteinLecithin-cholesterol acyltransferaseApolipoprotein ELecithin-cholesterol acyltransferaseApolipoprotein A4Lipoprotein lipaseLipase C, hepatic type
P682
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-IIIApolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipaseApolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins
P921
Q1316030-90F29817-82D3-4375-8A17-FCAA28B818E0Q14864755-083C4898-81F3-40AD-B7F5-5F9A2430693FQ14864757-3F4C9136-081D-4716-AFCC-3261859A183BQ14905444-44725906-896A-492F-8371-78D7E724BD79Q14905448-690FDB95-DB68-4AEE-A3DA-A7C3E4C7CC78Q14910072-3DB3DF8B-3144-4630-A12A-B896B1179F4AQ14914235-649C9F26-098E-456F-8956-A7BD75F29C3AQ14914235-B7E84574-4E72-4050-A600-41F2B579C502Q14916272-4C8560CC-751E-4CD9-940A-F3F25726FD6CQ21173178-32C2F034-7FBA-4AE5-88D1-53ABC0251121Q21201272-9E64217C-7573-41EF-9079-9EA334AC1A51Q21201272-F668D351-A8F8-43F3-82FA-503136C1FA5AQ21416505-7302AF66-0B98-494E-ACC0-EEF516F0CD35Q21416505-E02DDB7A-E910-4ECE-84C3-17C278CCAA9DQ21499492-EBC94A5F-B489-4804-9452-6B2E3AA4C908Q21980338-E319EC89-BC59-434A-8BD6-9048ABFAAD6EQ21987586-9285B0C9-7185-401C-BB13-F8CBEEAC274DQ22676900-475A2354-FB37-4ED4-AB26-7BF34A13B288Q28558120-2C7D0484-61FF-4D5F-89BD-A274130B7240Q28559375-C4021A45-3597-48DC-9E1B-044E9A91C6C5Q28560424-A53D8972-2341-4D70-BD66-60C3282715EAQ28560448-C2F9FD60-AFA5-496B-90E2-F5EAFABE9997Q28562617-43663C74-F808-4FA3-9A75-347FF3E35FF9Q28563279-68066519-EEC1-4FD2-A7A0-EB2127E9C343Q28563279-A986B0EB-F642-4442-89D7-9627D8B3C722Q29520346-D67BC571-FA36-4C66-A26E-3A893FEA7B4BQ29822735-14EA0116-991E-4649-8F6F-0AEAC111DD97Q29822762-F503D64C-519F-40A7-A7BF-DE9FDB2CD330Q29823063-391A610C-1769-4E49-AB08-FCAB7FB993A3Q29823063-62A07331-438E-401E-9C71-15E331B43967Q29823500-5406DBBE-DEA0-4A83-AE8F-D842A1080115Q29823666-5B4D0602-B9D2-4589-A024-7474AC764DB8Q29823799-2F775AC7-91B7-4D12-B384-2B48A54C973BQ29825084-DAE26F94-D67D-4501-986D-38CB561F69F6Q29827348-847122C7-1964-43AD-B21F-78BF9681F0C7Q29833390-0F4E9ED1-E074-4267-BC1E-839DBCD313E1Q3445743-B36BB793-03F2-4F5A-AACA-635576BA8937Q420014-F9C2EBD5-DB2A-419B-ADA0-37C6572BCCADQ424706-4506E0A5-E0F5-47D3-B796-AF9462BCF080Q424706-E1DC2B58-EEEE-4FB9-9C1F-F4DC0D86E527
P682
description
The acquisition, loss or modif ...... quent loss of free fatty acid.
@en
biologisch proces
@nl
name
very-low-density lipoprotein particle remodeling
@en
type
label
very-low-density lipoprotein particle remodeling
@en
altLabel
GO:0034372
@en
VLDL remodeling
@en
prefLabel
very-low-density lipoprotein particle remodeling
@en
P2888
P686
GO:0034372